Mobile App

Google Play Apple Store
Independent Conference Coverage from the American College of Chest Physicians Annual Meeting 2022*
AMA/ANCC/ACPE Activity - Clinical Clips
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within the field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American College of Chest Physicians Annual Meeting in Nashville, Tennessee, October 16-19, 2022, through a series of two ‘what you need to know in 5-minutes’ videos.
Claim AMA, ANCC, or ACPE credit/contact hour(s) after completion of each brief Post-Test/Evaluation.

Jean M. Elwing, MD Jean M. Elwing, MD
Professor of Medicine
Director, Pulmonary Hypertension Program
University of Cincinnati

* This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the American College of Chest Physicians Annual Meeting 2022.
Supported by independent educational grants from United Therapeutics, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson

Launch Date: October 17, 2022
Release Date: October 17, 2022
Expiration Date: September 30, 2023

September 30, 2023
Mini Module